Key Takeaways The S&P 500 gained 0.6% on Monday, March 31, boosted by an afternoon rally even as investors brace for the ...
Moderna shares may remain under the microscope on Tuesday after sinking to a five-year low following news that the Food and ...
Moderna Inc MRNA -11.5% Get Free Report shares were down 13.5% at $26.88 and Novavax Inc NVAX -9.02% Get Free Report shares ...
Shares of Moderna ( MRNA -9.35%) are falling on Monday. The company's stock lost 7.9% as of 1:30 p.m. ET and was down as much ...
A preprint study posted late last week on the server medRxiv reveals that the current Moderna COVID-19 vaccine is 53% effective against COVID-19–related hospitalization and 39% protective against ...
Moderna (MRNA) shares dropped nearly 12% following news that FDA official Peter Marks will step down on April 5th, causing ...
Total company revenue fell from a peak of $19.3 billion in 2022 to $3.2 billion for the full year ended Dec. 31, 2024. For ...
Moderna stock dips 10% amid FDA resignation, signaling regulatory risks. Strong cash reserves can't offset competitive and ...